The report by SwedenBIO contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be a basis for fact-based improvements of the industry and to promote Sweden’s position in pharmaceutical development.
Link to Swedish Drug Discovery and Development Pipeline Report 2023: swedenbio.se/reports >>